OGEN stock

Oragenics Inc (OGEN) support and resistance · rev $37.7K

Oragenics Inc (OGEN) is a biotechnology company listed on US.

This page maps Oragenics Inc (OGEN) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.

OGEN currently screens at market cap $2.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new OGEN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the OGEN quote page for the session range and the stock page for the full model.

Not investment advice.

Full OGEN analysis